Glycogen Synthase Kinase-3 Regulates Production of Amyloid-β Peptides and Tau Phosphorylation in Diabetic Rat Brain
The pathogenesis of diabetic neurological complications is not fully understood. Diabetes mellitus (DM) and Alzheimer’s disease (AD) are characterized by amyloid deposits. Glycogen synthase kinase-3 (GSK-3) plays an important role in the pathogenesis of AD and DM. Here we tried to investigate the pr...
Saved in:
Main Authors: | Zhong-Sen Qu, Liang Li, Xiao-Jiang Sun, Yu-Wu Zhao, Jin Zhang, Zhi Geng, Jian-Liang Fu, Qing-Guo Ren |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2014/878123 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Odontogenic differentiation of dental pulp stem cells by glycogen synthase kinase-3β inhibitory peptides
by: Vidhyashree Rajasekar, et al.
Published: (2025-02-01) -
Exploring novel and potent glycogen synthase kinase-3β inhibitors through systematic drug designing approach
by: Shabir Ahmad Ganai, et al.
Published: (2025-02-01) -
Glycogen Synthase Kinase 3β Promotes Postoperative Cognitive Dysfunction by Inducing the M1 Polarization and Migration of Microglia
by: Jingjin Li, et al.
Published: (2020-01-01) -
Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy
by: Eun Hee Ahn, et al.
Published: (2025-01-01) -
Inhibition of Glycogen Synthase Kinase and the Neuroprotective Function of Conjugated ZnO-Osthol Nanoparticles in Alzheimer’s Disease
by: Nahed S. Alharthi, et al.
Published: (2022-01-01)